LSC Webinars

  1. Integrated Thinking for Complex FIH Programs 2/25/2026

    See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.

  2. Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs 2/23/2026

    Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.

  3. Selecting A Prefillable Syringe System With Confidence 2/5/2026

    Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.

  4. Designing Drug Substance Processes For Fill-Finish Compatibility 2/4/2026

    Integrated KBI and Argonaut solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and practical strategies.

  5. Next-Level Cell Lines: An Integrated Approach To Biologic Innovation 1/22/2026

    See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.

  6. Five Practical Considerations To Move From Concept To Clinic 12/17/2025

    Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

  7. Eliminate Risk From Your Viral Vector Tech Transfers 12/5/2025

    Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

  8. Navigating Regulatory Expectations For Injectable Packaging 12/4/2025

    Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.

  9. Raising The Bar In Gene Therapy 12/1/2025

    Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.

  10. Extrusion-Based ASD Scale-Up: Performance Through Process Understanding 11/20/2025

    Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.